dc.contributor.author | Ganan, Monica | |
dc.contributor.author | Lorentzen, Silje Benedicte | |
dc.contributor.author | Aam, Berit Bjugan | |
dc.contributor.author | Eijsink, Vincent | |
dc.contributor.author | Gaustad, Peter | |
dc.contributor.author | Sørlie, Morten | |
dc.date.accessioned | 2020-07-31T10:21:08Z | |
dc.date.available | 2020-07-31T10:21:08Z | |
dc.date.created | 2020-01-22T15:51:44Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | PLOS ONE. 2019, 14 (12), 1-13. | en_US |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://hdl.handle.net/11250/2670562 | |
dc.language.iso | eng | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Antibiotic saving effect of combination therapy through synergistic interactions between well-characterized chito-oligosaccharides and commercial antifungals against medically relevant yeasts | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.source.pagenumber | 1-13 | en_US |
dc.source.volume | 14 | en_US |
dc.source.journal | PLOS ONE | en_US |
dc.source.issue | 12 | en_US |
dc.identifier.doi | 10.1371/journal.pone.0227098 | |
dc.identifier.cristin | 1780303 | |
dc.relation.project | Norges forskningsråd: 226280 | en_US |
cristin.unitcode | 192,12,0,0 | |
cristin.unitname | Kjemi, bioteknologi og matvitenskap | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |